sleep pattern and well being regulatie dag en nachtritme
Conditions
Interventions
Participating patients will be randomized to dynamic light or standard light.
-Continuous: actigraphy by Actiwatch
-Questionnaire at start, daily, weekly and eat the end of the study
.
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: • Patient at least 18 years old • Admitted to the haematology department in a private patient room equipped with dynamic light as well as standard light • Expected length of stay approximately 3 weeks with room arrest • Patients requiring intensive chemotherapy, due to AML, ALL, Burkitt Lymphoma, mantle cell lymphoma, and multiple myeloma
Exclusion criteria
Exclusion criteria: • Active depression, sleep disorder or delirium • Visual handicapped due to ocular pathologies like macula degeneration, severe cataract or severe diabetic retinopathy • Sleep apnoe syndrome • Extreme light sensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the difference in duration of wakefulness during the time presumed sleeping between both groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are subjective quality of sleep, depression, delirium as diagnosed by a psychiatrist, clinical parameters (complications, blood pressure, heart rate, temperature, pain score), duration of hospitalization, and medication with special attention to benzodiazepines, antipsychotics, antidepressants, corticosteroids, and other medication with known psychiatric side effect (such as voriconazole). | — |
Countries
Netherlands
Outcome results
None listed